GH insider trading
SEC Form 4 transactions reported by Guardant Health, Inc. insiders, officers, directors, and 10%+ beneficial owners. Sourced from EDGAR.
Want this data via API instead of reading about it? Get a free API key →
Recent GH insider transactions
The 20 most recent non-derivative Form 4 transactions reported by Guardant Health, Inc. insiders. Buys are highlighted; the transaction code column matches SEC Form 4 codes (P = open-market purchase, S = sale, A = grant, M = option exercise, F = tax withholding).
| Date | Code | Insider | Role | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-16 | S | Krognes Steve E. | Director | 1,300 | $176 | $229K |
| 2026-09-16 | S | Krognes Steve E. | Director | 1,103 | $174 | $192K |
| 2026-09-16 | S | Krognes Steve E. | Director | 971 | $177 | $172K |
| 2026-09-16 | S | Krognes Steve E. | Director | 3,300 | $175 | $579K |
| 2026-09-16 | S | Azar Alex M II | Director | 826 | $175 | $145K |
| 2026-09-16 | S | Tariq Musa | Director | 116 | $175 | $20K |
| 2026-09-15 | S | Chudova Darya | Chief Technology Officer | 7,738 | $178 | $1.4M |
| 2026-09-15 | M | Tariq Musa | Director | 249 | n/a | |
| 2026-09-12 | M | Azar Alex M II | Director | 1,651 | n/a | |
| 2026-09-11 | S | Kalia Kumud | Chief Information Officer | 4,000 | $158 | $632K |
| 2026-08-26 | G | Eltoukhy Helmy | Co-Chief Executive Officer, Director | 30,000 | n/a | |
| 2026-08-26 | J | Eltoukhy Helmy | Co-Chief Executive Officer, Director | 25,000 | n/a | |
| 2026-08-26 | J | Eltoukhy Helmy | Co-Chief Executive Officer, Director | 25,000 | n/a | |
| 2026-08-21 | S | Talasaz AmirAli | Co-Chief Executive Officer, Director | 20,888 | $169 | $3.5M |
| 2026-08-21 | S | Talasaz AmirAli | Co-Chief Executive Officer, Director | 9,023 | $168 | $1.5M |
| 2026-08-21 | S | Talasaz AmirAli | Co-Chief Executive Officer, Director | 7,589 | $170 | $1.3M |
| 2026-08-21 | M | MIGNONE ROBERTO | Director | 264 | n/a | |
| 2026-08-17 | M | Hidalgo Medina Manuel | Director | 232 | n/a | |
| 2026-08-17 | S | Tariq Musa | Director | 116 | $156 | $18K |
| 2026-08-15 | M | Tariq Musa | Director | 250 | n/a |
What insider trading data covers for GH
Guardant Health, Inc. (CIK 1576280) reports Section 16 insider transactions on Form 4 within two business days. Each filing carries the transaction date, transaction code (P for open-market purchase, S for sale, M for option exercise, F for tax withholding), shares, price, and post-transaction holdings. Optional footnotes disclose Rule 10b5-1 plan references and indirect ownership relationships.
How to interpret GH insider activity
Treat each filing line through three filters: the transaction code, the role of the filer (officer carries more signal than director), and the dollar value relative to the company's market cap. Open-market purchases (P) by C-suite officers carry the strongest bullish signal. Sales (S) referencing a Rule 10b5-1 plan in the footnotes are pre-arranged and should be discounted. See how to read a Form 4 for the full walkthrough.
Get GH insider data via API
Pull recent GH Form 4 filings, filtered to open-market purchases above $100k:
curl "https://api.edgarkit.com/v1/filings?ticker=GH&form_type=4&transaction_code=P&min_value=100000&limit=20" \
-H "Authorization: Bearer YOUR_API_KEY"
Subscribe via webhook to receive every new GH Form 4 in real time:
curl -X POST "https://api.edgarkit.com/v1/webhooks" \
-H "Authorization: Bearer YOUR_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"url": "https://your-server.com/edgarkit-events",
"filters": {"form_types": ["4"], "tickers": ["GH"]}
}'
Cluster buying detection for GH
The strongest insider signal at the issuer level is cluster buying: three or more distinct insiders placing open-market purchases within a 7-14 day window. For the complete pattern detector, see how to detect insider cluster buying.